XML 47 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
Revenue (Tables)
12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Product
Revenue by product for the periods indicated were as follows:
Twelve Months Ended December 31,
(In thousands)20242023
CHEMOSAT$4,902 $2,065 
HEPZATO KIT32,303 — 
Total revenue$37,205 $2,065 
Schedule of Revenue and Accounts Receivable Concentrations
The Company’s total percentage of revenue and accounts receivable balances were comprised of the following concentrations from its largest customers, based on whose revenue or accounts receivable concentration is greater than 10% of total revenue or total accounts receivable in the periods disclosed below.
For the twelve months ended and as of December 31, 2024
% of Revenue% of Accounts Receivable
Customer 120.1 %10.1 %
Customer 217.7 %30.2 %
Customer 313.2 %3.4 %
Customer 411.3 %16.8 %
For the twelve months ended and as of December 31, 2023
% of Revenue% of Accounts Receivable
Customer 117.4 %— %
Customer 216.6 %— %
Customer 313.2 %21.1 %
Customer 413.1 %10.5 %
Customer 511.9 %10.5 %
Customer 610.7 %20.2 %
Customer 75.5 %10.9 %